ArticleCancer science2023
TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations.
Kei Oguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleCancer science2023
Kei Oguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.